New data on rotavirus vaccine from Mexico and Africa show lifesaving impact and effectiveness in the developing world

For the first time ever, studies in Mexico and Africa, published in the New England Journal of Medicine, demonstrate a reduction in diarrheal disease deaths following rotavirus vaccine introduction in Mexico and vaccine efficacy among impoverished populations in Malawi and South Africa. The findings from these studies informed the World Health Organization’s (WHO) recent recommendation that rotavirus vaccines be included in every nation’s immunization program.

Read the full press release.